By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

REPLICor Inc. 

1550 Metcalfe Street, Suite 502

Montreal  Quebec  H3A1X6  Canada
Phone: 514-842-9849 Fax: 514-842-1505


SEARCH JOBS








Company News
REPLICor Inc. Announces Publication Of Its REP 101 And REP 102 Studies Demonstrating The Therapeutic Effect Of Naps And The Achievement Of Functional Control Off Treatment In Human Patients With Chronic Hepatitis B Infection 6/7/2016 8:43:57 AM
REPLICor Inc. To Make Three Presentations At EASL 2016 4/4/2016 11:00:58 AM
REPLICor Inc. To Present Pre-Clinical And Updated Clinical Data On REP 2139-Ca Based Combination Therapy In Chronic HBV And HBV / HDV Co-Infection At APASL 2016 2/16/2016 11:51:48 AM
REPLICor Inc. To Present Pre-Clinical And Clinical Data On REP 2139-Ca Based Combination Therapy In Chronic HBV / HDV Co-Infection At HEPDART 2015 12/1/2015 10:36:16 AM
REPLICor Inc. Discloses Continued Improvement Of The Antiviral Response In Patients With HBV / HDV Co-Infection Receiving REP 2139-Ca Based Combination Therapy 11/16/2015 10:16:12 AM
REPLICor Inc. Announces Publication Of Its Pre-Clinical Data On The Therapeutic Effect Of Naps On Hepatitis B Virus Infection 11/12/2015 12:35:25 PM
REPLICor Inc. Announces Grant Of US Patents On HBV / HDV Treatment Methods Combining HBsAg Reduction And Immunotherapy 11/9/2015 10:50:57 AM
REPLICor Inc. To Present An Update On The Safety And Efficacy Of REP 2139-Ca Based Combination Therapy In Chronic HBV / HDV Co-Infection At American Association for Study of Liver Diseases 2015 11/3/2015 10:49:25 AM
REPLICor Inc. Presents Updated Mechanistic Data And Pre-Clinical Interferon-Free Combination Treatment Data In HBV And HBV / HDV Co-Infection 10/15/2015 8:23:00 AM
REPLICor Inc. Announces Initiation Of Recruitment For Its Phase IIb Clinical Trial With REP 2139-Mg Or REP 2165-Mg In Combination With Viread And Pegasys Or Zadaxin In Patients With Hbeag Negative Chronic Hepatitis B Infection 10/5/2015 10:51:02 AM
123
//-->